• 1. Evolutionary approaches in protein engineering towards biomaterial construction
  Brindha J.,Balamurali M. M.,Kaushik Chanda RSC Adv., 2019,9, 34720-34734
• 2. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
• 3. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 4. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 5. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Nitrobenzenes
• Solvents and Organic Chemicals Organic Compounds Amines/Sulfonamides

Recent Advances in the Study of 4-Fluoro-5-nitrobenzene-1,2-diamine (CAS: 113269-06-0) in Chemical Biology and Pharmaceutical Research

The compound 4-Fluoro-5-nitrobenzene-1,2-diamine (CAS: 113269-06-0) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential applications in drug development. This research brief aims to summarize the latest findings related to this compound, focusing on its synthesis, biological activity, and therapeutic potential. Recent studies have highlighted its role as a key intermediate in the synthesis of heterocyclic compounds, which are widely used in medicinal chemistry.

One of the most notable advancements in the study of 4-Fluoro-5-nitrobenzene-1,2-diamine is its application in the development of novel kinase inhibitors. Kinases are critical targets in cancer therapy, and researchers have successfully utilized this compound to design potent inhibitors with high selectivity and efficacy. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that derivatives of 4-Fluoro-5-nitrobenzene-1,2-diamine exhibited strong inhibitory activity against specific oncogenic kinases, suggesting its potential as a lead compound for anticancer drug development.

In addition to its role in kinase inhibition, recent research has explored the compound's utility in the synthesis of fluorescent probes. These probes are essential tools for studying biological processes at the molecular level. A study in Chemical Communications (2023) reported the successful incorporation of 4-Fluoro-5-nitrobenzene-1,2-diamine into a fluorescent dye, which exhibited excellent photostability and sensitivity for detecting reactive oxygen species (ROS) in live cells. This breakthrough opens new avenues for real-time monitoring of oxidative stress in disease models.

Another area of interest is the compound's potential in antimicrobial research. A 2022 study in Bioorganic & Medicinal Chemistry Letters revealed that 4-Fluoro-5-nitrobenzene-1,2-diamine derivatives displayed significant activity against drug-resistant bacterial strains, including methicillin-resistant Staphylococcus aureus (MRSA). The study attributed this activity to the compound's ability to disrupt bacterial cell wall synthesis, making it a promising candidate for the development of new antibiotics.

Despite these promising findings, challenges remain in optimizing the pharmacokinetic properties of 4-Fluoro-5-nitrobenzene-1,2-diamine derivatives. Recent work has focused on improving their solubility and bioavailability through structural modifications. For instance, a 2023 study in European Journal of Medicinal Chemistry proposed the use of prodrug strategies to enhance the delivery of these compounds to target tissues, thereby increasing their therapeutic efficacy.

In conclusion, 4-Fluoro-5-nitrobenzene-1,2-diamine (CAS: 113269-06-0) represents a versatile and valuable scaffold in chemical biology and pharmaceutical research. Its applications span from kinase inhibition and fluorescent probe development to antimicrobial therapy, showcasing its broad potential. Future research should focus on addressing the current limitations and further exploring its therapeutic applications in preclinical and clinical settings.

• 364-74-9(2,5-Difluoronitrobenzene)
• 364-76-1(4-Fluoro-3-nitroaniline)
• 367-81-7(2,4-Dinitro-5-fluoroaniline)
• 78925-50-5(1,3-Benzenediamine, 5-fluoro-2,4,6-trinitro-)
• 567-63-5(3-Fluoro-2-nitroaniline)
• 364-44-3(Benzene,2-fluoro-1,3,5-trinitro-)
• 21397-11-5(2-Fluoro-3-nitroaniline)
• 1542-36-5(2,5-Difluoro-4-nitroaniline)
• 2369-13-3(3-fluoro-4-nitroaniline)
• 361-72-8(3,5-Difluoro-2-nitroaniline)